* ArGEN X and AbbVie to collaborate on ARGX-115
against novel immuno-oncology target
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
The post BRIEF-ArGEN X and AbbVie to collaborate on argx-115 against novel immuno-oncology target appeared first on NASDAQ.